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Plasma citrate levels were found to be elevated in non-alcoholic fatty liver disease (NAFLD) patients.
Cellular experiments indicated that increased citrate levels might originate from an excess of fatty
acids. The impact of elevated citrate levels on oxidative stress was examined. It was found that cit-
rate stimulated hydrogen peroxide induced intracellular oxidative stress in HepG2 cells. This was
related to the promotion of iron mediated hydroxyl radical formation from hydrogen peroxide by
citrate. The stimulating effect of citrate on the reactivity of iron promotes oxidative stress, a crucial
process in the progression of NAFLD.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Non-alcoholic fatty liver disease (NAFLD) is the most common
liver disease in Western society with a prevalence of 20–30%
[1,2]. It is considered as the hepatic manifestation of the metabolic
syndrome, which is caused by an unhealthy lifestyle including high
caloric intake and low physical activity. NAFLD represents a spec-
trum of liver disorders ranging from steatosis to non-alcoholic ste-
atohepatitis (NASH), ﬁbrosis, cirrhosis and hepatocellular
carcinoma. The majority of patients have benign steatosis only,
but 25–30% of patients develop NASH [3], evolving to a systemic
inﬂammation with the development of severe liver and cardiovas-
cular diseases and cancer.In the development of NASH, oxidative stress plays a crucial
role. Oxidative stress is deﬁned as an imbalance in the production
of reactive oxygen species (ROS) and the protection against these
ROS in favor of the production. Numerous causes of oxidative
stress can be found in NAFLD [4]. Among others, oxidative pro-
cesses in the mitochondria (b-oxidation, citric acid cycle, oxidative
phosphorylation) produce ROS, such as hydrogen peroxide and the
superoxide radical. Several compounds, e.g., fatty acids, stimulate
the generation of these ROS and thereby enhance oxidative stress
[5].
In our outpatient clinic, patients presenting with liver test
abnormalities were evaluated for NAFLD. During metabolic screen-
ing of the patients it was observed that citrate levels were elevated.
The present study aims to elucidate the consequence of this obser-
vation and addresses the role of citrate in NAFLD. The focus is on
the effect of citrate on oxidative stress.
2. Materials and methods
2.1. Patients and tissue sampling
Patients presenting with liver enzyme elevations were evalu-
ated for NAFLD/NASH by extensive blood and urine investigations
Table 1
Patient characteristics.
Characteistics Study population
Age (yr) 55 ± 11
Male gender (n) 5
BMI (kg/m2) 30.5 ± 3.6
<25 (n) 0
25–29.9 (n) 5
>30 (n) 6
Hypertension (>130/85) (n) 9
cGT (U/L) 161 ± 125 a
AST (U/L) 59 ± 22a
ALT (U/L) 93 ± 35a
Fasting glucose (mmol/l) 6.6 ± 1.4a
Total cholesterol (mmol/l) 5.5 ± 1.1
HDL cholesterol (mmol/l) 1.3 ± 0.3
LDL cholesteol (mmol/l) 3.3 ± 0.7
Triglyceride (mmol/l) 1.9 ± 0.9a
Albumin (g/l) 44.1 ± 3.3
Citric acid plasma (lmol/l) 161 ± 35a
a Above the reference values. Abbreviations: AST: aspartate
aminotransaminase, ALT: alanine aminotransferase, cGT: gam-
maglutamyl transferase. Characteristics are presented as
mean ± standard deviation or as number of patients out of a total
of 11 (n).
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according to liver biopsy were enrolled in this study. The study
was performed following the ethical guidelines of the academic
hospital and all patients gave informed consent to use their data.
The data were collected according to routine clinical practice of
our outpatient clinic and anonymised for the study. Active viral
disease, alcoholic liver disease, haemochromatosis, copper storage
disease, a-1-antitrypsine deﬁciency and drug induced liver disease
were ruled out in all patients. Citrate blood plasma levels were
determined in all patients included in the study.
2.2. Reagents
Minimum essential medium, fetal bovine serum, Dulbecco’s
phosphate buffered saline (DPBS), penicillin and streptomycin
were purchased from Invitrogen (Breda, the Netherlands). Other
reagents used were obtained from Sigma Aldrich (Zwijndrecht,
the Netherlands).
2.3. Cell culture
Human hepatoma cells (HepG2 cells) were cultured at 37 C un-
der an atmosphere of 5% CO2 in minimum essential medium con-
taining 10% fetal bovine serum, 1% non-essential amino acids,
1 mM sodium pyruvate, 100 units/ml penicillin and 100 lg/ml
streptomycin.
2.4. Determination of citrate in HepG2 cells
HepG2 cells were plated 5  105 cells/well in a six wells plate.
After growing to conﬂuence, cells were exposed to serum free
medium containing 1 mM of palmitic acid and 1% bovine serum
albumin for 24 h. Control HepG2 cells were exposed to serum free
medium containing 1% bovine serum albumin. After 24 h, cells
were harvested, counted and lysed. Citrate levels in the cell lysate
were measured by liquid chromatography–tandem mass spec-
trometry, adapted from Keevil et al. [6]. Cells were stained with
Oil red O to conﬁrm fat accumulation. For this purpose the cells
were ﬁxated with 10% formalin and washed with 60%
isopropanol.
2.5. Measurement of intracellular oxidative stress
The production of intracellular reactive oxygen species was
measured using 2,7-dichloroﬂuorescin diacetate (DCFH-DA) [7].
HepG2 cells were plated 1  105 cells/well in a 96 wells plate. After
24 h, cells were incubated with 5 lMDCFH-DA for 15 min at 37 C.
After incubation with DCFH-DA, cells were washed with DPBS to
remove any DCFH-DA that was not taken up by the cells. Then cells
were exposed for one hour to 250 lM sodium citrate or 500 lM so-
dium citrate in DPBS or DPBS alone. After one hour, 500 lM hydro-
gen peroxide (H2O2) or DPBS was added and the ﬂuorescence was
measured (Ex 485, Em 538) for 30 min with the use of a Spectra-
max microplate reader.
2.6. Cell viability measurement by lactate dehydrogenase leakage
Cell viability was measured as leakage of lactate dehydrogenase
(LDH) from cells in the medium. Directly after the incubation, the
mediumwas collected and frozen. LDH activity was measured with
use of the substrate pyruvate (initial concentration 100 mM) as the
reduction of the absorbance at 340 nm caused by the consumption
of the cofactor NADH (initial concentration 0.35 mM). The rate of
absorbance decline is proportional to LDH activity. LDH activity
in the samples was compared to LDH activity in samples obtained
of cells treated with Triton-X.2.7. Determination of hydroxyl radical production with deoxyribose
Production of hydroxyl radicals (OH) was measured with the
use of 2-deoxy-D-ribose (Deoxyribose) as detector [8]. In the reac-
tion of deoxyribose with hydroxyl radicals, a breakdown product
of deoxyribose is formed, that is detected after a condensation reac-
tion with thiobarbituric acid which gives rise to an increase in
absorption at 532 nm. The reaction of ferrous ions (Fe2+) with
H2O2 generates hydroxyl radicals. This is known as the Fenton reac-
tion [9]. The stimulating effect of citrate on the formation of hydro-
xyl radicals was determined. Reaction mixtures contained 2.8 mM
deoxyribose, 100 lM ascorbic acid and varying concentrations of
sodium citrate dissolved in a 20 mM potassium phosphate buffer
(pH 7.4). The reaction was started with the addition of 10 mM
H2O2 and 100 lM ferric chloride (FeCl3). After one hour incubation
at 37 C, 1.4% trichloroacetic acid and 0.5% thiobarbituric acid dis-
solved inmilliQ water were added to stop the reaction and the mix-
tures were heated at 100 C for 20 min. The absorption at 532 nm
was measured with a Varian Cary 50 spectrophotometer.
2.8. Determination of hydroxyl radical production with electron spin
resonance
To detect hydroxyl radicals produced in the Fenton reaction by
electron spin resonance (ESR) using spin-trapping, H2O2 (10 mM)
and ferrous sulphate (FeSO4) (100 lM) were incubated with or
without citrate (300 lM) in the presence of 5-diethoxyphospho-
ryl-5-methyl-1-pyrroline N-oxide (DMPO) (70 mM) in a 20 mM
potassium phosphate buffer. As a control the experiment was per-
formed without FeSO4. All ESR experiments were performed at
9.8 GHz using a Bruker ESR 300 EMX spectrometer (Bruker GmbH,
Karlsruhe, Germany) and operating at a center ﬁeld strength of
3488 G with 65 G as sweep width, a modulation amplitude of 1 G
and microwave power of 10 mW. The time constant and the con-
version time were 40.96 and 20.48 ms, respectively, and the results
are the average of 10 scans. The ESR spin trapping experiments
were performed by placing the samples in a 100 ll glass capillary
immediately after H2O2 addition, and the spectra were recorded
within 1 min after starting the reaction. The height of the signal
over the ESR spectrum is proportional to the amount of hydroxyl
radicals formed.
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The effect of citrate on oxygen consumption by a 100 lM FeSO4
solution was measured using a Tamson YSI 5300 oxygen monitor.
The FeSO4 solution was added to 1 ml 50 mM tris HCl buffer, with
150 mM NaCl (pH 7.4 at 37 C) while oxygen tension was mea-
sured [10]. The FeSO4 solution was prepared immediately before
use. When indicated, 300 lM of citrate was added before addition
of the FeSO4 solution to investigate the effect of citrate on the oxy-
gen consumption of FeSO4.
2.10. Statistics
Results were presented as mean ± standard deviation. Statistics
were performed using the student t-test. Repeated measurements
ANOVA was used for the time curves obtained during the intracel-
lular oxidative stress measurements. A P-value below 0.05 was
considered to be signiﬁcant.Fig. 1. Effect of palmitic acid on intracellular citrate levels in HepG2 cells. (A and B)
Intracellular lipid accumulation in HepG2 cells treated with palmitic acid (B),
compared to untreated HepG2 cells (A), shown by Oil red O staining, magniﬁcation
20 times. (C) Intracellular citrate concentrations in HepG2 cells incubated with
palmitic acid (+ palmitic acid) and in untreated HepG2 cells ( palmitic acid).
Mean + S.D. are shown (n = 6). ⁄P < 0.001.3. Results
3.1. Citrate levels in NAFLD patients
Eleven patients (5 male, 6 female) with a mean age of 55 years
(range 38–70 years) were included in this study. Patients’ charac-
teristics are summarized in Table 1. All patients had one or more
features of the metabolic syndrome according to ATP III criteria
for clinical identiﬁcation of the metabolic syndrome. They all were
overweight (BMI >25 kg/m2) and 6 patients were obese (BMI
>30 kg/m2) with mainly abdominal fat deposition. Nine patients
had elevated blood pressure (>130/85 mmHg), ﬁve patients had
elevated triglyceride levels (P1.7 mmol/l) and nine patients had
elevated fasting glucose levels (>5.6 mmol/l). All patients did not
take antihypertensive or lipid and glucose lowering drugs at time
of the study. Liver biopsy conﬁrmed NASH in 9 out of 11 patients.
Liver biopsies in these patients showed signs of steatosis, lobular
inﬂammation and in most patients ﬁbrosis. Two patients had stea-
tosis only.
Citrate levels in NAFLD patients were signiﬁcantly increased
(mean 161 ± 35 lmol/l) compared to reference values (mean
79 ± 14 lmol/l), (P < 0.0001).
3.2. Stimulation of citrate formation in HepG2 cells by palmitic acid
HepG2 cells treated with palmitic acid showed evident fat accu-
mulation compared to untreated control cells (Fig. 1A and B). The
intracellular citrate level was elevated in palmitic acid treated cells
(330.4 ± 45.1 lmol/l) compared to untreated control cells
(168.0 ± 51.0 lmol/l), (P < 0.001) (Fig. 1C).
3.3. Increase of intracellular oxidative stress by citrate
HepG2 cells treated with 250 or 500 lM citrate in combination
with H2O2, showed a signiﬁcant increase in the production of intra-
cellular ROS compared to cells incubated with H2O2 alone (Fig. 2),
(P < 0.05). In control experiments, the formation of ROS in HepG2
cells treated with 250 and 500 lM citrate did not increase com-
pared to that in untreated cells (not depicted).
3.4. Cell viability
The viability of cells incubated in 500 lM H2O2 (mean
94.6 ± 0.6%), 500 lM citrate (mean 90.0 ± 3.5%) or the combination
of H2O2 and citrate (mean 88.6 ± 8.7%) was not signiﬁcantlydifferent from the viability of cells incubated in PBS alone (mean
92.3 ± 3.3%).
3.5. Stimulation of hydroxyl radical production by citrate determined
with deoxyribose
Citrate increased the formation of hydroxyl radicals in the Fen-
ton reaction (Fig. 3A) (P < 0.05). A plateau in hydroxyl formation
was reached at a concentration of 500 lM of citrate.
3.6. Stimulation of hydroxyl radical production by citrate determined
with ESR
The incubation of DMPO with H2O2 and ferrous ions resulted in
DMPO/OH signal z (aN and aHb = 14.9 G) [11] (Fig. 3B). The
Fig. 2. Stimulation of intracellular oxidative stress in HepG2 cells by citrate and H2O2. Intracellular oxidative stress in HepG2 cells incubated with 250 and 500 lM
citrate + H2O2, incubated with H2O2 alone and incubated in DPBS alone. Mean are shown (n = 5). Repeated measurements ANOVA conﬁrmed a signiﬁcant difference in the
increase in oxidative stress when using 250 and 500 lM citrate + H2O2 compared to using H2O2 alone (P < 0.05). Control experiments with citrate alone did not increase
intracellular oxidative stress compared to the control (not depicted).
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DMPO/OH signal (Fig. 3B), indicating an increase in the formation
of hydroxyl radicals. The degree of increase was comparable to the
increase found in the deoxyribose assay (1.3 times more OH). The
combination of H2O2 and citrate without Fe2+ did not generate a
DMPO/OH signal (not depicted). Also H2O2 alone did not result
in a DMPO/OH signal (not depicted).
3.7. Iron (II) induced oxygen consumption
Addition of 100 lM of FeSO4 to the Tris–HCl buffer decreased
oxygen tension with an initial rate of 6 lMO2/min (Fig. 3C). Citrate
increased the oxygen consumption by FeSO4 three-fold to a rate of
18 lM O2/min (Fig. 3C). Addition of citrate alone to the Tris–HCl
buffer did not decrease oxygen tension.
4. Discussion
The primary observation that initiated the present study was
our ﬁnding that plasma citrate levels were increased in NAFLD pa-
tients (101–210 lmol/l) compared to reference values (52–
106 lmol/l), (P < 0.0001). The explanation for the elevated citrate
levels can be found in the high levels of free fatty acids and glucose
in these patients, associated with the metabolic syndrome. Both
nutrients are broken down into acetyl-CoA, which leads to citrate
formation in the citric acid cycle (Fig. 4). The citric acid cycle or
Krebs cycle is the central metabolic process of the cell [12]. In
the ﬁrst step citrate is formed from oxaloacetate and acetyl-CoA.
High levels of free fatty acids, seen in patients with the metabolic
syndrome and NAFLD, boost the formation of citrate in the ﬁrst
step. This is caused by an increased acetyl-CoA inﬂux into the citric
acid cycle and a stimulation of oxaloacetate formation from pyru-
vate (Fig. 4). Because the third step in the citric acid cycle (isoci-
trate–dehydrogenase) is the key rate-limiting step and the
second step in the cycle (aconitase) is reversible, citrate will accu-
mulate. Experiments with HepG2 cells conﬁrmed that high levelsof fatty acids (palmitic acid) indeed lead to elevated citrate levels
in the cytosol of liver cells.
From a chemical perspective, citrate is an odd intermediate in
the oxidative breakdown of nutrients because it lacks a functional
group that can be oxidized under physiological conditions; its
three carboxyl groups are fully oxidized and its hydroxyl group is
a tertiary alcohol that is resistant to oxidation. This chemical prop-
erty and the accumulation in patients prompted us to further
examine the inﬂuence of citrate on oxidative stress, as oxidative
stress plays an important role in the progression of NAFLD to the
chronic inﬂammatory status causing NASH.
Citrate added to HepG2 cells did not increase intracellular oxi-
dative stress. However, oxidative stress did increase when citrate
was used in combination with hydrogen peroxide. Hence, we con-
clude that citrate does not have an effect on oxidative stress di-
rectly, but citrate promotes oxidative stress indirectly.
Apparently citrate aggravates oxidative stress caused by hydro-
gen peroxide. Hydrogen peroxide is not a radical by itself, because
it does not contain an unpaired electron. It is relatively non-reac-
tive. However, in combination with iron ions it leads to the forma-
tion of the highly reactive hydroxyl radical in the Fenton reaction
[9]. The hydroxyl radical is considered to be the most noxious
ROS, which can damage virtually any cellular component, includ-
ing DNA, proteins and lipids. In experiments investigating the ef-
fect of citrate on the Fenton reaction (experiments with
deoxyribose and ESR), citrate appeared to stimulate hydroxyl rad-
ical formation from hydrogen peroxide in the presence of iron. This
is probably caused by its iron chelating ability. In the iron–citrate
complex, iron apparently is more prone to react with hydrogen
peroxide. Our ﬁndings corroborate previous studies that also dem-
onstrated that citrate stimulates hydroxyl radical formation in the
Fenton reaction [13–15]. Similar stimulating effects have been
found for other chelating agents, such as EDTA [13,14,16]. In a
study evaluating fourteen iron chelators, citrate appeared to be
one of the strongest stimulators of iron-induced hydroxyl radical
formation [13].
Fig. 3. Stimulation of iron reactivity by citrate. (A) Formation of hydroxyl radicals in
the Fenton reaction measured with deoxyribose using various concentrations of
citrate compared to control (no citrate). Mean ± S.D. are shown (n = 2). (B)
Formation of hydroxyl radicals in the Fenton reaction with and without citrate
measured with ESR. The height of the ESR signal is proportional for the amount of
hydroxyl radicals formed. (C) Oxygen tension in a Tris–HCl buffer after addition of a
FeSO4 solution and after addition of a citrate solution and a FeSO4 solution,
measured in an oxygen chamber.
Fig. 4. Schematic representation of the pathways leading to citrate formation. In
the metabolic syndrome the presence of excessive fats and carbohydrates gives rise
to elevated citrate levels according to the pathways depicted. During glycolysis
glucose is converted into pyruvate. This is converted into oxaloacetate by pyruvate
carboxylase and into acetyl-CoA by pyruvate dehydrogenase. During b-oxidation a
fatty acid and coenzyme A (CoA) are converted into a two carbon atoms shorter
fatty acid (fatty acid-2C) and acetyl-CoA. In the ﬁrst step of the citric acid cycle,
acetyl-CoA and oxaloacetate combine to form citrate. Citrate can promote oxidative
stress by stimulating the reactivity of iron.
B. van de Wier et al. / FEBS Letters 587 (2013) 2461–2466 2465In the oxygen consumption experiment it was demonstrated
that citrate also increases the reactivity of iron toward oxygen. Cit-
rate enhances the rate of oxygen consumption by iron. This is in
line with the effect of other iron chelating compounds that also in-
crease iron reactivity toward oxygen [10].
In NAFLD patients, hepatic iron levels are commonly elevated
[17,18]. Although the role of iron in NAFLD is multifactorial and
not fully understood, the consensus is that this transition metal in-
creases oxidative stress [19–21]. Promotion of radical production
via the Fenton reaction is probably the most important cause of
the increase in oxidative stress. The observed increase in oxidative
stress in HepG2 cells treated with hydrogen peroxide and citrate
could be explained by stimulation of iron reactivity, leading to an
increase in hydroxyl radical formation. Serum ferritin, the iron
storage protein, is also often elevated in patients with NAFLD. A
correlation between serum ferritin levels and the severity of histo-
logic abnormality has been observed in patients with NAFLD
[22,23]. Before iron stored in ferritin can promote radical forma-
tion, it has to be released from ferritin. Interestingly, the release
of iron from ferritin requires chelation (e.g. by citrate) [24,25].
Thus, apart from stimulating the production of hydroxyl radicals
in the Fenton reaction directly, citrate could also increase oxidative
stress in NAFLD by recruiting iron from ferritin, making more iron
available for the Fenton reaction.Apart from NAFLD, citrate levels are also elevated in citrin deﬁ-
ciency. Citrin deﬁciency is caused by a rare genetic defect that re-
sults in a dysfunctional mitochondrial aspartate-glutamate carrier.
This leads to a compensatory up regulation of the malate-citrate
carrier, resulting in elevated cytosolic citrate levels [26]. Patients
with citrin deﬁciency can develop NAFLD and NASH without pre-
senting other features of the metabolic syndrome. The develop-
ment of NAFLD in these patients is still enigmatic, but as
suggested by the data of the present study, the radical promoting
potential of citrate might come into the picture in the pathogenesis
of this disease.
Although several treatments for NASH have been investigated,
no registered drug therapy is available to date. The present study
opens a new perspective for the treatment of NASH. The oxidative
stress promoting effect of citrate might be counteracted by iron
chelators that can compete with citrate for iron and that preferen-
tially inhibit the Fenton reaction or scavenge the radicals that are
formed.
In conclusion, the elevation of citrate levels measured in NAFLD
patients can be caused by the breakdown of abundant free fatty
acids. Citrate stimulates the reactivity of iron, which leads to pro-
motion of radical formation. This results in an augmentation of oxi-
dative stress which is of relevance for the progression of NAFLD
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